IMMUNE AMERICA INC
S-8, 1996-12-12
BLANK CHECKS
Previous: PRAIRIE PACIFIC ENERGY CORP, 6-K, 1996-12-12
Next: MORGAN STANLEY GROUP INC /DE/, 424B3, 1996-12-12





    As filed with the Securities and Exchange Commission on December 12, 1996

                            File No. 333-___________
 -------------------------------------------------------------------------------
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM S-8
             Registration Statement Under the Securities Act of 1993


                              IMMUNE AMERICA, INC.
- --------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)



    State of Nevada                                             75-2641513    
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation or           (IRS Employer ID No.)
                 Organization


                       211 West Wall, Midland, Texas 79701
- --------------------------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)


                        Agreement for Consulting Services
- --------------------------------------------------------------------------------
                            (Full Title of the Plan)


                 Secretary, 211 West Wall, Midland, Texas 79701
- --------------------------------------------------------------------------------
                     (Name and Address of Agent For Service)

                                 (915) 682-1761
- --------------------------------------------------------------------------------
          (Telephone Number, Including Area Code, of Agent For Service)

If any of the  securities  being  registered on this Form are to be offered on a
delayed or continuous  basis  pursuant to Rule 415 under the  Securities  Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following line: X
                                             --

                         CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
<S>                                                                            <C>             <C>           
====================================================================================================================
                                                  Proposed Maximum       Proposed Maximum
Title of Securities to                           Offering Price Per     Aggregate Offering
     be Registered           Amount to be             Share (1)                Price                Amount of
                              Registered                                                        Registration Fee
- --------------------------------------------------------------------------------------------------------------------
     Common Stock               758,008                 $.08                $60,640.64               $100.00
- --------------------------------------------------------------------------------------------------------------------
(1) Estimated  pursuant to Rule 457(c) of the  Securities Act of 1933 solely for
the purpose of  calculating  the  registration  fee, based on the average of the
high and low bid prices of the Common Stock on December 12, 1996.

        Page 1 of 11 pages contained in the sequential numbering system.
  The Exhibit Index may be found on Page 6 of the sequential numbering system.
</TABLE>
<PAGE>


Item 3.  Incorporation of Certain Documents by Reference.

The following  documents are  incorporated  by reference in to the  registration
statement:

1.   The Company's  Annual Report on Form 10-KSB for the year ended December 31,
     1995;

2.   The Company's Quarterly Reports on Form 10-QSB for the quarters ended March
     31, 1996, June 30, 1996 and September 30, 1996;

3.   The Company's Report on Form 8-K filed September 16, 1996.

All documents  filed by the Company  pursuant to Sections  13(a),  13(c),  14 or
15(d) of the Securities Exchange Act of 1934, as amended, subsequent to the date
hereof and prior to the filing of a  post-effective  amendment  which  indicates
that all  securities  offered  hereby have been sold or which  de-registers  all
securities   covered  hereby  then  remaining  unsold  shall  be  deemed  to  be
incorporated  as by  reference  herein  and to be part  hereof  from the date of
filing of such  documents,  except as to any  portion  of any  future  Annual or
Quarterly  Report to  Stockholders  which is deemed to be modified or superseded
for purposes of this Registration Statement to the extent that such statement is
replaced or modified by a statement  contained in a subsequently  dated document
incorporated by reference or contained in this Registration Statement.

Item 4.  Description of Securities.

The   Certificate   of   Incorporation,   as  amended   (the   "Certificate   of
Incorporation")  of the Company authorizes the issuance of 100,000,000 shares of
Common Stock, par value $.001 per share. Holders of Common Stock are entitled to
one vote for each share on each matter submitted to a vote of stockholders.  All
outstanding  shares of Common Stock of record are fully paid, validly issued and
nonassessable  and the  holders  of Common  Stock have no  preemptive  rights to
subscribe for or to purchase any  additional  securities  issued by the Company.
The Certificate of Incorporation  does not provide for cumulative  voting.  Upon
liquidation,  dissolution  or winding up of the  Company,  the holders of Common
Stock are  entitled to share  ratably in the  distribution  of assets  remaining
after payment of debts and expenses.  There are no  conversion,  sinking fund or
redemption  provisions,  or any restrictions on alienability with respect to the
Common Stock.

Item 5.  Interests of Named Experts and Counsel.

The  validity of the  issuance  of the  securities  registered  pursuant to this
registration  statement  is being  passed  upon for the  Company  by  Morgan  F.
Johnston, Attorney, 5825 Steeplechase, Dallas, Texas 75093.

Item 6.  Indemnification of Directors and Officers.

The  General  Corporation  Law of Nevada  permits  provisions  in the  articles,
by-laws or  resolutions  approved  by  shareholders  which  limit  liability  of
directors for breach of fiduciary duty to certain specified  circumstances.  The
Company's  by-laws  indemnify  its  Officers  and  Directors  to the full extent
permitted  by Nevada law.  The by-laws with  certain  exceptions  eliminate  any
personal liability of a Director to the Company or its shareholders for monetary
damages for the breach of a Director's  fiduciary  duty and therefore a Director
cannot be held liable for damages to the Company or its  shareholders  for gross
negligence  or lack of due  care in  carrying  out  his  fiduciary  duties  as a
Director.  The Company's Articles provide for indemnification to the full extent
permitted under law which includes all liability, damages, and costs or expenses
arising  from or in  connection  with  service  for,  employment  by,  or  other
affiliation  with the Company to the maximum extent and under all  circumstances
permitted by law.  Nevada law permits  indemnification  if a director or officer
acts in good faith in a manner reasonably believed to be in, or not opposed to ,
the  best  interest's  of  the  corporation.  A  director  or  officer  must  be
indemnified  as  to  any  matter  in  which  he  successfully  defends  himself.
Indemnification  is prohibited as to any matter in which the director or officer
is  adjudged  liable  to  the  corporation.   Insofar  as  indemnification   for
liabilities  arising  under the  Securities  Act may be permitted to  directors,
officers,  and  controlling  persons of the Company  pursuant  to the  foregoing
provisions or otherwise, the Company has been advised that in the opinion of the
Securities  and Exchange  Commission,  such  indemnification  is against  public
policy as expressed in the Act and is, therefore, unenforceable.


                                       2
<PAGE>

Item 7.  Exemption from Registration Claimed.

Does not apply

Item 8.  Exhibits.

5.1  Opinion of Morgan F. Johnston,  Esq. regarding legality (including consent)

24.1 Consent  of  Cheshier  &  Fuller,  Inc.,  a  professional  corporation,  as
     Accountants

Item 9.  Undertakings.

The undersigned registrant hereby undertakes:

(1)  To file,  during any period in which offers or sales are being made, a post
     effective amendment to this registration statement:

(i)  To include any  prospectus  required by Section  10(a)(3) of the Securities
     Act of 1933;

(ii) To  reflect  in the  prospectus  any  facts or  events  arising  after  the
     effective  date  of  the   registration   statement  (or  the  most  recent
     post-effective amendment thereof) which,  individually or in the aggregate,
     represent  a  fundamental  change  in  the  information  set  forth  in the
     registration statement;

(iii)To  include  any  material   information   with  respect  to  the  plan  of
     distribution not previously disclosed in the registration  statement or any
     material change to such information in the registration statement;

     Provided, however, that paragraphs (1) (i) and (1) (ii) do not apply if the
information  required  to be  included in a  post-effective  amendment  by those
paragraphs  is  contained  in periodic  reports  filed with or  furnished to the
Commission  by the  registrant  pursuant  to Section 13 or Section  15(d) of the
Securities  Exchange  Act of 1934  that are  incorporated  by  reference  in the
registration statement.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of post effective amendment any of
the securities  being  registered  which remain unsold at the termination of the
offering.

     (4) The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of 1934  (and,  where  applicable,  each  filing of an
employee  benefit  plan's  annual  report  pursuant  to  Section  15(d)  of  the
Securities  Exchange  Act of 1934)  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     (5) The undersigned  registrant hereby undertakes to deliver or cause to be
delivered with the prospectus,  to each person to whom the prospectus is sent or
given,  the latest annual  report to security  holders that is  incorporated  by
reference  in  the  prospectus  and  furnished   pursuant  to  and  meeting  the
requirements  of Rule 14a-3 or Rule 14c-3 under the  Securities  Exchange Act of
1934;  and,  where  interim  financial  information  required to be presented by
Article 3 of Regulation S-X are not set forth in the prospectus,  to deliver, or
cause to be  delivered to each person to whom the  prospectus  is sent or given,
the latest  quarterly  report that is specifically  incorporated by reference in
the prospectus to provide such interim financial information.

     (6) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the  registrant  pursuant  to  the  foregoing  provisions,   or  otherwise,  the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore,  unenforceable. In the event that a claim for indemnification
against such  liabilities 


                                       3
<PAGE>

(other than the  payment by the  registrant  of  expenses  incurred or paid by a
director,  officer or  controlling  person of the  registrant in the  successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling  person in connection with the securities being  registered,  the
registrant  will,  unless in the  opinion  of its  counsel  the  matter has been
settled by controlling precedent,  submit to a court of appropriate jurisdiction
the question  whether such  indemnification  by it is against  public  policy as
expressed  in the Act and will be  governed  by the final  adjudication  of such
issue.
























































                                       4
<PAGE>



                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  Registrant
certifies  that is has  reasonable  grounds  to  believe  that it meets  all the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on  its  behalf  by  the  undersigned  thereunto  duly
authorized, in the City of Midland, State of Texas, on the 12th day of December,
1996.

IMMUNE AMERICA, INC.



BY:     s/s  Glenn A. Little
       --------------------------
       Glenn A. Little, President

Pursuant to the  requirements on the Securities Act of 1933,  this  Registration
Statement has been signed below by the following  persons in the  capacities and
on the dates indicated.
<TABLE>
<CAPTION>
<S>                                                                                 <C>                 

Signature                                         Title                                  Date


/s/   Glenn A. Little                          President and Chairman                December 12, 1996
- --------------------------------
      Glenn A. Little


/s/  Kevin B. Halter, Jr.                      Director                              December 12, 1996
- --------------------------------
     Kevin B. Halter, Jr.


/s/  Dr. Elizabeth Huntley                     Vice President, Principal             December 12, 1996
- --------------------------------
      Dr. Elizabeth Huntley                    Financial Officer and Director

/s/ Matthew Blair                              Director
- --------------------------------                                                     December 12, 1996
     Matthew Blair

</TABLE>




                                       5
<PAGE>



                                  Exhibit Index
<TABLE>
<CAPTION>
<S>                                                                            <C> 

                                                                           Sequential
                                                                           Page Number
Exhibit No.        Document                                                Or Location
                                                                           ------------

5.1                Opinion of Morgan F. Johnston, Esq. regarding
                   legality (including consent)

24.1               Consent of Cheshier & Fuller, Inc.,
                   a professional corporation, as Accountants


</TABLE>







<PAGE>






















                                   EXHIBIT 5.1




































<PAGE>




                               MORGAN F. JOHNSTON
                                 Attorney-at-Law
                                5825 Steeplechase
                               Plano, Texas 75093
                              Phone: (972) 239-2761
                               Fax: (972) 239-2761



December 12, 1996


Immune America, Inc.
211 West Wall
Midland, Texas 79701


    Re:  S-8 Registration Statement


Gentlemen:

    At  your  request,  I have  examined  the  form of  Registration  Statement,
No.333-________,   which  you  are  filing  with  the  Securities  and  Exchange
Commission, on Form S-8 (the "Registration  Statement"),  in connection with the
registration  under the Securities  Act of 1933, as amended,  of an aggregate of
758,008 shares of your Common Stock (the "Stock")  issuable to consultants under
the Agreement for Consulting Services (the "Plan").

    In rendering the following opinion, I have examined and relied only upon the
documents,  and  certificates  of officers  and  directors of the Company as are
specifically described below. In my examination,  I have assumed the genuineness
of all signatures, the authenticity,  accuracy and completeness of the documents
submitted to me as originals,  and the conformity with the original documents of
all  documents  submitted  to me as copies.  My  examination  was limited to the
following documents and no others:

     1. Certificate of Incorporation of the Company, as amended to date;

     2. Bylaws of the Company, as amended to date;

     3. Certified  Resolutions  adopted by the Board of Directors of the Company
     authorizing the Plan and the issuance of the Stock under the Plan;

     4. The Registration Statement; and

     5. The Form of Plan. I have not  undertaken,  nor do I intend to undertake,
     any  independent  investigation  beyond such  documents and records,  or to
     verify the adequacy of accuracy of such documents and records.

                                      
<PAGE>

    Based on the  foregoing,  it is my opinion that the Stock to be issued under
the Plan, subject to effectiveness of the Registration  Statement and compliance
with applicable blue sky laws, and execution of the Plan in the form referred to
herein,  when  issued  under  the Plan or  otherwise,  will by duly and  validly
authorized, fully paid and non-assessable.

    I express no opinion as to compliance with the securities or "blue sky" laws
of any state in which the Stock is  proposed to be offered and sold or as to the
effect, if any, which  non-compliance  with such laws might have on the validity
of issuance of the Stock.

    I consent  to the filing of this  opinion  as an exhibit to any filing  made
with  the  Securities  and  Exchange  Commission  or  under  any  state or other
jurisdiction's  securities  act for the purpose of  registering,  qualifying  or
establishing  eligibility for an exemption from registration or qualification of
the  Stock  described  in the  Registration  Statement  in  connection  with the
offering  described therein.  Other than as provided in the preceding  sentence,
this opinion (i) is addressed  solely to you, (ii) may not be relied upon by any
other party,  (iii) covers only matters of Nevada and federal law and nothing in
this  opinion  shall be deemed to imply any  opinion  related to the laws of any
other jurisdiction,  (iv) may not be quoted or reproduced or delivered by you to
any  other  person,  and (v) may  not be  relied  upon  for  any  other  purpose
whatsoever. Nothing herein shall be deemed to relate to or constitute an opinion
concerning any matters not specifically set forth above.

     The  information  set  forth  herein  is as of the date of this  letter.  I
disclaim  any  undertaking  to advise you of changes  which may be brought to my
attention after the effective date of the Registration Statement.


Very truly yours,

/s/ Morgan F. Johnston

Morgan F. Johnston



                                      
<PAGE>






















                                  EXHIBIT 24.1




















<PAGE>



                                  EXHIBIT 24.1


               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

To the Board of Directors
Immune America, Inc.


We have issued our report dated March 26, 1996, on the balance  sheets of Immune
America,  Inc..  as of December 31, 1995 and 1994 and the related  statements of
operations,  changes in  shareholder  equity and cash flows for the three  years
ended.  December 31, 1995,  1994 and 1993.  We consent to the  incorporation  by
reference of our report in the Registration Statement of Immune America, Inc. on
Form S-8.


CHESHIER & FULLER,  INC., a professional corporation




December 12, 1996












<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission